| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Entyvio 108 mg/0.68 mL injection, 0.68 mL syringe |
has intended active ingredient |
True |
vedolizumab |
Inferred relationship |
Some |
1166243302 |
| Entyvio 108 mg/0.68 mL injection, 0.68 mL syringe |
has Australian BoSS |
True |
vedolizumab |
Inferred relationship |
Some |
1166243302 |
| vedolizumab 108 mg/0.68 mL injection, pen device |
has Australian BoSS |
True |
vedolizumab |
Inferred relationship |
Some |
1346665958 |
| vedolizumab 108 mg/0.68 mL injection, pen device |
has intended active ingredient |
True |
vedolizumab |
Inferred relationship |
Some |
1346665958 |
| Entyvio 108 mg/0.68 mL injection, 0.68 mL pen device |
has Australian BoSS |
True |
vedolizumab |
Inferred relationship |
Some |
1611866650 |
| Entyvio 108 mg/0.68 mL injection, 0.68 mL pen device |
has intended active ingredient |
True |
vedolizumab |
Inferred relationship |
Some |
1611866650 |
| vedolizumab 108 mg/0.68 mL injection, syringe |
has intended active ingredient |
True |
vedolizumab |
Inferred relationship |
Some |
1344724506 |
| vedolizumab 108 mg/0.68 mL injection, syringe |
has Australian BoSS |
True |
vedolizumab |
Inferred relationship |
Some |
1344724506 |
| Entyvio 300 mg powder for injection, 300 mg vial |
has intended active ingredient |
True |
vedolizumab |
Inferred relationship |
Some |
685317290 |
| vedolizumab |
has intended active ingredient |
True |
vedolizumab |
Inferred relationship |
Some |
1 |
| vedolizumab 300 mg injection, vial |
has intended active ingredient |
True |
vedolizumab |
Inferred relationship |
Some |
795708502 |
| vedolizumab 300 mg injection, vial |
has Australian BoSS |
True |
vedolizumab |
Inferred relationship |
Some |
795708502 |
| Entyvio 300 mg powder for injection, 300 mg vial |
has Australian BoSS |
True |
vedolizumab |
Inferred relationship |
Some |
685317290 |